Synapse

← JEADV Clinical Practice

Papers in JEADV Clinical Practice

Page 10 · newest first

  1. Lip necrosis caused by methicillin‐resistant Staphylococcus aureus (MRSA)JEADV Clinical Practice · 2024
  2. Rare cutaneous manifestation of B‐cell chronic lymphocytic leukaemia involving the toesJEADV Clinical Practice · 2024
  3. Off‐label use of rituximab for dermatologic conditions: A single center reviewJEADV Clinical Practice · 2024
  4. Understanding disparities in hidradenitis suppurativa through social and structural determinants of healthJEADV Clinical Practice · 2024
  5. Discoid lupus erythematosus in the conchal bowlJEADV Clinical Practice · 2024
  6. Purpuric patches on the thighs of a boyJEADV Clinical Practice · 2024
  7. Efficacy of a dermocosmetic skin care regimen in reducing acne‐associated post‐inflammatory hyperpigmentation in subjects with phototypes IV to VIJEADV Clinical Practice · 2024
  8. Cutaneous manifestations of systemic diseases in Afro‐Caribbean skinJEADV Clinical Practice · 2024
  9. Pityriasis Rubra Pilaris refractory to ustekinumab successfully treated with guselkumabJEADV Clinical Practice · 2024
  10. Diffuse hyperpigmented macules in a 48‐year‐old womanJEADV Clinical Practice · 2024
  11. Undertreatment of acne vulgaris in Dutch adolescents: A complex interplay of socioeconomic, sex and ethnic‐related differencesJEADV Clinical Practice · 2024
  12. Risk and maintenance factors in body‐focused repetitive behavioursJEADV Clinical Practice · 2024
  13. A tricky singular papular peri‐cicatricial mammarian lesionJEADV Clinical Practice · 2024
  14. The utility of layering systemic therapies in connective tissue diseasesJEADV Clinical Practice · 2024
  15. TARC/CCL17 reflects the severity of pemphigus (pemphigus vulgaris and pemphigus foliaceus) at the initial presentationJEADV Clinical Practice · 2024
  16. High‐intensity focused ultrasound: Safety and efficacy of a novel treatment modality for neurofibromatosis type 1 cutaneous neurofibromaJEADV Clinical Practice · 2024
  17. Early‐onset idiopathic pyoderma gangrenosumJEADV Clinical Practice · 2024
  18. Fatigue is associated with disease severity in adult patients with hidradenitis suppurativaJEADV Clinical Practice · 2024
  19. ChatGPT for skin cancer prevention: High patients' satisfaction to educational materialJEADV Clinical Practice · 2024
  20. Social media as a recruitment tactic in melanoma education and protective behaviors in Latino patientsJEADV Clinical Practice · 2024
  21. Update on pulse corticosteroid therapy for the management of alopecia areataJEADV Clinical Practice · 2024
  22. Efficacy and safety of wide field radiation therapy for extensive skin field cancerization remains unprovenJEADV Clinical Practice · 2024
  23. Malignant melanoma and spina bifidaJEADV Clinical Practice · 2024
  24. Skin cancers and their precursors in Finnish liver transplantation recipients: A follow‐up studyJEADV Clinical Practice · 2024
  25. Palmar pitsJEADV Clinical Practice · 2024
  26. Treatment and referral patterns of patients with atopic dermatitis from the Danish primary care system to the tertiary care systemJEADV Clinical Practice · 2024
  27. Dactylolysis spontanea (ainhum)JEADV Clinical Practice · 2024
  28. A practical guide to over‐the‐counter treatments for hyperpigmentationJEADV Clinical Practice · 2024
  29. Topical ruxolitinib 1.5% (JAK1/JAK2 inhibitor) improves clinical and patient‐reported outcomes in moderate to severe chronic hand dermatitis: Data from a small open‐label trialJEADV Clinical Practice · 2024
  30. Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practiceJEADV Clinical Practice · 2024
  31. Adherence to treatment in dermatology: Literature reviewJEADV Clinical Practice · 2024
  32. Identification and functional validation of a novel pathogenic POT1 germline variant p.G95V in familial melanomaJEADV Clinical Practice · 2024
  33. First report of ATP2A2 somatic mosaicism occurring during embryogenesis in transient acantholytic dermatosisJEADV Clinical Practice · 2024
  34. Hyperpigmentation in skin of colour: Therapeutical benefits of isobutylamido‐thiazolyl‐resorcinol (Thiamidol®), an effective tyrosinase inhibitor, in phototypes IV–VIJEADV Clinical Practice · 2024
  35. Keloid treatment assessment measures: A literature reviewJEADV Clinical Practice · 2024
  36. Paradoxical granulomatous reaction to ustekinumabJEADV Clinical Practice · 2024
  37. The comparative burden of chronic spontaneous urticaria, atopic dermatitis and psoriasis in five European countriesJEADV Clinical Practice · 2024
  38. Sezary syndrome revealed by PD‐L1 blockade for tumor stage mycosis fungoidesJEADV Clinical Practice · 2024
  39. Multisystem inflammatory syndrome in adult with features of Kawasaki diseaseJEADV Clinical Practice · 2024
  40. Atopic dermatitis and stress: A functional magnetic resonance imaging study of female patients with atopic dermatitis using an arithmetic taskJEADV Clinical Practice · 2024
  41. Circulating basophils in patients with type IIb autoimmune chronic spontaneous urticaria have a lower histamine contentJEADV Clinical Practice · 2024
  42. Circulating TWEAK levels in patients with acne vulgaris: Effect of oral isotretinoin therapyJEADV Clinical Practice · 2024
  43. Dermatological manifestations in the intensive care unit of a third‐level hospitalJEADV Clinical Practice · 2024
  44. Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trialJEADV Clinical Practice · 2024
  45. Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopeciaJEADV Clinical Practice · 2024
  46. Evolution of patient demographics, baseline clinical characteristics and outcomes in Phase 3 trials of biologics (TNFi, IL12/23i, IL17i, IL23i), PDE4i and TYK2i for psoriasisJEADV Clinical Practice · 2024
  47. Report of novel treatment of segmental vitiligo using combined microneedling and topical ruxolitinibJEADV Clinical Practice · 2023
  48. Histopathologic features of selumetinib‐induced paronychia in a child with neurofibromatosis type 1JEADV Clinical Practice · 2023
  49. The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population‐based survey studyJEADV Clinical Practice · 2023
  50. Ex vivo assessment of basal cell carcinoma surgical margins in Mohs surgery by autofluorescence‐Raman spectroscopy: A pilot studyJEADV Clinical Practice · 2023